This is the limited version of the Vernalis company profile: Join LinkedIn or Sign In to see more information.
Vernalis is a development stage pharmaceutical company with significant expertise both in de novo fragment and structure-based drug discovery and pre-clinical and clinical development.
The Group has seven product candidates in clinical development (two of which are partnered), two programmes in pre-clinical (one with a partner) and other competitive research programmes.
Your Connections to Vernalis
Popular Profiles at Vernalis
Last edited by Senior Team Leader, Medicinal Chemistry
613 Reading Road
Oakdene Court
Winnersh, Berkshire
RG41 5UA
United Kingdom
Phone: 44 11 8977 3133
Fax: 44 11 8989 9300
| Headquarters | Cambridge, United Kingdom |
|---|
| Industry | Pharmaceuticals |
|---|
| Type | Public Company |
|---|
| Status | Operating |
|---|
| Company Size |
85 employees
|
|---|
| 2006 Revenue |
16
mil
[GBP]
(16%)
|
|---|
| Founded | 1986 |
|---|
| Website | http://www.vernalis.com |
|---|
| Top Schools |
| Univ. of Cambridge | 11% |
| Loughborough Univ. | 7% |
|
Estimated based on LinkedIn Data
Career path for Vernalis employees
Vernalis employees are most connected to
In partnership with 
Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.
This LinkedIn Company Profile was created by LinkedIn and is about Vernalis. This page is not endorsed by or affiliated with Vernalis. For questions regarding LinkedIn Company Profiles, contact us.
Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions
